Company: HCTI
Filing Date: 2025-02-18
Form Type: 10-K/A
Source: 0001213900-25-014503
Chunk: 55

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-18
Form: 10-K/A
Chunk 55
---
          
 Securities to be   
 issued Upon        
 Exercise of        
 Outstanding        
 Options, Warrants, 
 and Rights (a)     |         |     | Weighted Average  
 Exercise Price of 
 Outstanding       
 Options (b)       |     |     | Number of        
 Securities       
 Remaining        
 Available for    
 Future Issuance  
 Under Equity     
 Compensation     
 Plans (Excluding 
 Securities       
 Reflected in     
 column (a)) (c)  |           |
|:-------------------------------------------------------|:----|:-------------------|--------:|:----|:------------------|----:|:----|:-----------------|----------:|
| Equity compensation plans approved by stockholders (1) |     |                    | 276,500 |     | $                 | 3.7 |     |                  | 1,023,050 |
| Total                                                  |     |                    | 276,500 |     | $                 | 3.7 |     |                  | 1,023,050 |

| (1) | The Plan permits grants of equity awards to employees, directors,                                                                      
 consultants and other independent contractors. Our board of directors and shareholders have approved a total reserve of 600,000 shares 
 for issuance under the Plan.                                                                                                           |

| (2) | The total reserve of 600,000 shares represents 13.92%of the 
 equity on a fully diluted basis.                            |

We have not issued any options outside of the Plan. Transfer Agent The transfer agent for the common stock is VStock Transfer LLC, 18 Lafayette Place, Woodmere, New York, telephone (212) 828-8436. Item 6. [Reserved] The Company is a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and is not required to provide the information required under this item. 35 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations. The following discussion summarizes the significant factors affecting the operating results, financial condition, liquidity, and cash flows of our Company as of and for the periods presented below. The following discussion and analysis should be read in conjunction with the condensed consolidated financial statements and the related notes thereto, and the consolidated financial statements and the related notes thereto all included elsewhere in this report. The statements in this discussion regarding industry outlook, our expectations regarding our future performance, liquidity, and capital resources, and all other non-historical statements in this discussion are forward-looking statements and are based on the beliefs of our management,